INTERNATIONAL CLINICAL TRIALS IN RADIATION ONCOLOGY

1984年秋天，放射肿瘤学国际联络员 提出了合作小组。 这次联络的主要目的 是为了正式建立一个更积极的组织联盟， 做临床试验，以实现：1）更好的沟通， 积极的试验; 2）更好地保证放射治疗的质量; 3)更好地定义患者进入研究;以及4）更好地 导致选定的组间研究，以加速患者的累积。 1986年在法国巴黎举行的首次会议是为了 设立一个合作小组来促进这些目标。 名称 国际放射肿瘤临床试验（International Clinical Trials in Radiation Oncology） （ICTRO）。 组织者来自三个现有的合作社 组：放射治疗肿瘤学组（RTOG），欧洲 癌症治疗研究组织（EORTC） 英国医学研究理事会（BMRC） 联盟 由此形成的将寻求促进癌症研究试验， 试图在双方达到同样的卓越水平， 大西洋和太平洋。 此外，ICTRO的发展 作为双边协议的核心主题， 向第三世界转让技术的良好机制 国家 这将主要通过质量保证来实现 机制等 编写一份研究文件， 确定优先事项，确定资源，概述质量保证 标准，并提出一个可行的研究方案是结束 这是1986年巴黎会议的成果。 目前的提案将 允许出版本研究计划和进一步发展 对抗癌症的一项重大新进展 国际吧

In the Fall of 1984, an international liaison of radiation oncology cooperative groups was proposed. The primary aims of this liaison were to formalize a more active federation of the organizations doing clinical trials to achieve: 1) better communication on active trials; 2) better quality assurance of radiation treatment; 3) better definition of patient entry on to study; and 4) better leads to selected intergroup studies to accelerate patient accrual. The initial conference held in Paris, France in 1986 was to establish a cooperative group to facilitate these aims. The name selected was International Clinical Trials in Radiation Oncology (ICTRO). The organizers were from three existing cooperative groups: Radiation Therapy Oncology Group (RTOG), European Organization for Research in the Treatment of Cancer (EORTC) and the British Medical Research Council (BMRC). The alliance thus formed will seek to promote cancer research trials and attempt to achieve the same level of excellence on both sides of the Atlantic and Pacific oceans. Further, development of ICTRO as a Core Subject in Bilateral Agreements will make it an excellent mechanism for technology transfer to Third World countries. This will be achieved largely through quality assurance mechanisms. The development of a research document designed to establish priorities, define resources, outline quality assurance standards and present a workable research program is the end result of the Paris 1986 conference. The current proposal will permit publication of this research plan and further development of a significant new advance in the battle against cancer worldwide.